It has been about a month since the last earnings report for Agilent Technologies (A). Shares have added about 9.6% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. In turn, Agilent ...

The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approach ...

Agilent Technologies (NYSE:A) will release its quarterly earnings report on Wednesday, 2025-05-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Agilent ...

Agilent Technologies stock (ISIN US00846U1016) closed at USD 167.83 on the NYSE on October 2, 2026, up 0.69 percent for the ...

Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell ...

Agilent Technologies is a major player in the diagnostics and research industry, with a focus on laboratory-focused solutions. The company has shown resilience and strong growth potential, with a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SANTA CLARA, Calif. -- (BUSINESS WIRE)--Sep. 29, 2026-- Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis ...

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

Agilent Technologies stock (NYSE: A), which provides instruments and consumables for laboratories, trades at $113 per share, 10% below the level seen in March 2021. Agilent’s stock was trading at ...

Agilent Technologies, a $35 billion leader in global life sciences, is trading 30% below its all-time high and 20% down year-to-date, presenting a potential growth/value opportunity. Despite ...